Taking fundraising to new heights: Canadians climb 5,000 feet for prostate cancer research



Toronto, ON - March 9, 2017 - Over the course of the last few weeks, corporate teams located in Vancouver, Calgary and Toronto raised more than $650,000 for prostate cancer research by competing in Prostate Cancer Canada’s (PCC) 4th annual Step Up Challenge, presented by Scotiabank.

The Step Up Challenge involves teams of five competing in a 5,000 foot race up a number of the tallest skyscrapers across Canadian cities. Since 2014 the events have raised over $2,300,000 to support Prostate Cancer Canada.


Corporate teams in Vancouver Step Up for men with prostate cancer and their families

"It is when we come together as a community and challenge ourselves to reach new heights that we are able to expand the boundaries of what is possible,” explained PCC President and CEO, Rocco Rossi. “In that very spirit, participants of Step Up have pushed themselves to the limit in order to bring greater hope to men with prostate cancer and their families."
 
Keyera
EllisDon
great-gulf


The top fundraisers in Vancouver, Calgary, and Toronto were EllisDon, Keyera and Great Gulf, respectively.

In addition to presenting sponsor Scotiabank, PCC would like to thank sponsors Sanofi, Astellas, Kinross, CBTU, EllisDon, Cadillac Fairview, and The Canadian Brew House, as well as building partners Oxford, GWL Realty Advisors, Brookfield, Cominar, and Dream.

-30-

About Prostate Cancer Canada
Prostate Cancer Canada is the leading national foundation dedicated to the elimination of the most common cancer in men through research, advocacy, education, support and awareness. As one of the largest investors in prostate cancer research in Canada, Prostate Cancer Canada is committed to continuous discovery in the areas of prevention, diagnosis, treatment, and support.

For more information please contact:
Adam Miller
Manager, Communications
Prostate Cancer Canada
416 441 2131 ext. 235
adam.miller@prostatecancer.ca



Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More

Plaid for Dad participation skyrockets in third year

July 7, 2017 - TORONTO, ON - Launched for the first time in 2015, Prostate Cancer Canada's (PCC) Plaid for Dad campaign has further established itself as the way Canadians are choosing to give back on Father's Day weekend.
More


Click here for news archive